XML 30 R19.htm IDEA: XBRL DOCUMENT v3.8.0.1
Summary of Significant Accounting Policies (Tables)
12 Months Ended
Dec. 31, 2017
Accounting Policies [Abstract]  
Schedule of Business Acquisitions, by Acquisition

The allocation of the consideration transferred is as follows:

 

Shares issued in connection with Merger:        
Atrinsic 25,867 shares Common stock   $ 32,334  
Atrinsic Series A preferred stock as converted to Series B preferred
stock, 297,468 shares
    371,835  
Total value of shares issued to Atrinsic on Merger     404,169  
Fair value of net assets identified     -  
         
Goodwill     404,169  
Net value of consideration   $ -  

Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis

The following table provides a summary of financial instruments that are measured at fair value as of December 31, 2017.

 

    Carrying     Fair Value Measurement Using  
    Value     Level 1     Level 2     Level 3     Total  
                                         
Marketable securities     1,285,753             1,285,753             1,285,753  
Derivative warrants liabilities   $ (425,838 )   $     $     $ (425,838 )   $ (425,838 )

 

The following table provides a summary of financial instruments that are measured at fair value as of December 31, 2016.

 

    Carrying     Fair Value Measurement Using  
    Value     Level 1     Level 2     Level 3     Total  
                                         
Derivative warrants liabilities   $ (516,870 )   $     $     $ (516,870 )   $ (516,870 )

Schedule of Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation

The table below provides a summary of the changes in fair value, including net transfers in and/or out, of all financial assets and liabilities measured at fair value on a recurring basis using significant unobservable inputs (Level 3) during the year ended December 31, 2017:

 

   

Fair Value Measurement

Using Level 3 Inputs

 
    Total  
Balance, December 31, 2016   $ 516,870  
Change in fair value of derivative warrants liabilities     (91,032 )
Balance, December 31, 2017   $ 425,838  

Schedule of Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques

    February 12, 2016     December 31, 2016     December 31, 2017  
Exercise price   $ 1.25     $ 1.25       1.25  
Risk free interest rate     1.20 %     1.93 %     1.98 %
Dividend yield     0.00 %     0.00 %     0.00 %
Expected volatility     156 %     219 %     144 %
Contractual term     5.0 years       4.25 years       3.15 Years  

Schedule of Antidilutive Securities Excluded From Computation of Earnings Per Share

    Potentially Outstanding
Dilutive Common Shares
 
    For the Year
Ended
December 31, 2017
    For the Year
Ended
December 31, 2016
 
             
Conversion Feature Shares                
                 
Common shares issuable under the conversion feature of preferred shares     872,766       872,766  
                 
Stock Option     3,566,299       2,484,445  
                 
Warrant     3,826,658       3,826,658  
                 
Total potentially outstanding dilutive common shares     8,265,723       7,183,869